{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:19:15Z","timestamp":1791296355008,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","award":["12146"],"award-info":[{"award-number":["12146"]}],"id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","award":["12146"],"award-info":[{"award-number":["12146"]}],"id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aims to explore the priorities and counselling needs of patients with muscle-invasive bladder cancer faced with a decision between radical cystectomy and trimodality therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a qualitative study according to the phenomenological approach. Sixteen muscle-invasive bladder cancer survivors who underwent radical cystectomy or trimodality therapy completed a semi-structured interview between May 2022 and February 2023. Patients were recruited via Ghent University Hospital and a patient organisation. Data were analysed with inductive thematic analysis by a multi-disciplinary team using an iterative approach and investigators\u2019 triangulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Four main priorities determining the treatment decision were identified. (1) curing the disease; (2) health-related quality of life (physical, mental and social); (3) confidence in the treatment, which was mainly based on trust in the clinician; and (4) personal attributes. Trust in the clinician can be achieved by fulfilling the patient\u2019s information needs (accurate, complete, clear, impartial, personalised, realistic, and transparent information), ensuring accessibility of the clinician, and creating a clear and personalised treatment plan, involving patients to the extend they desire. Many patients considered a patient decision aid as a valuable asset in this process.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Priorities vary between patients with muscle-invasive bladder cancer. Identifying individual priorities and offering personalised information about them is crucial for ensuring trust in the clinician and confidence in the treatment. Use of a patient decision aid can be beneficial in this process.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-11927-1","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T19:03:28Z","timestamp":1706727808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice"],"prefix":"10.1186","volume":"24","author":[{"given":"Flor","family":"Verghote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Van Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Berquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas","family":"Lumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Decaestecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vanneste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Rammant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Fonteyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"issue":"20","key":"11927_CR1","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1200\/JCO.2016.69.2327","volume":"35","author":"GS Kulkarni","year":"2017","unstructured":"Kulkarni GS, Hermanns T, Wei Y, Bhindi B, Satkunasivam R, Athanasopoulos P, et al. Propensity score analysis of Radical Cystectomy Versus bladder-sparing Trimodal Therapy in the setting of a multidisciplinary bladder Cancer Clinic. J Clin Oncol. 2017;35(20):2299\u2013305.","journal-title":"J Clin Oncol"},{"issue":"2","key":"11927_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.urolonc.2017.10.002","volume":"36","author":"O Fahmy","year":"2018","unstructured":"Fahmy O, Khairul-Asri MG, Schubert T, Renninger M, Malek R, K\u00fcbler H, et al. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2018;36(2):43\u201353.","journal-title":"Urol Oncol"},{"issue":"5","key":"11927_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ijrobp.2016.08.023","volume":"96","author":"KS Mak","year":"2016","unstructured":"Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, et al. Quality of life in long-term survivors of muscle-invasive bladder Cancer. Int J Radiat Oncol Biol Phys. 2016;96(5):1028\u201336.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"11927_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","volume":"24","author":"AR Zlotta","year":"2023","unstructured":"Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet Oncol. 2023;24(6):669\u201381.","journal-title":"Lancet Oncol"},{"issue":"6","key":"11927_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1023\/A:1025144617752","volume":"12","author":"MF Botteman","year":"2003","unstructured":"Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A. Quality of life aspects of bladder cancer: a review of the literature. Qual Life Res. 2003;12(6):675\u201388.","journal-title":"Qual Life Res"},{"issue":"1","key":"11927_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.eururo.2014.02.038","volume":"66","author":"G Ploussard","year":"2014","unstructured":"Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, R\u00f6del CM, et al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol. 2014;66(1):120\u201337.","journal-title":"Eur Urol"},{"key":"11927_CR7","unstructured":"NICE. Bladder cancer: diagnosis and management 2015. https:\/\/www.nice.org.uk\/guidance\/ng2\/evidence\/full-guideline-pdf-3744109. Accessed 1 Nov 2023."},{"issue":"6","key":"11927_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.clon.2021.03.015","volume":"33","author":"MJ Costin","year":"2021","unstructured":"Costin MJ, Makaroff LE. Bladder preservation with Radiotherapy: the patient perspective. Clin Oncol (R Coll Radiol). 2021;33(6):346\u20139.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"11927_CR9","doi-asserted-by":"publisher","first-page":"102231","DOI":"10.1016\/j.ejon.2022.102231","volume":"61","author":"M St\u00e5hlgren","year":"2022","unstructured":"St\u00e5hlgren M, Forsell C, Drott J. Information needs in patients with bladder cancer undergoing radical cystectomy - A qualitative review with thematic synthesis. Eur J Oncol Nurs. 2022;61:102231.","journal-title":"Eur J Oncol Nurs"},{"issue":"6","key":"11927_CR10","doi-asserted-by":"publisher","first-page":"151226","DOI":"10.1016\/j.soncn.2021.151226","volume":"37","author":"E Rammant","year":"2021","unstructured":"Rammant E, Fonteyne V, Van Goethem V, Verhaeghe S, Raes A, Van Hemelrijck M, et al. Supportive Roles of the Health Care Team throughout the illness trajectory of bladder Cancer patients undergoing Radical Cystectomy: a qualitative study exploring the patients\u2019 perspectives. Semin Oncol Nurs. 2021;37(6):151226.","journal-title":"Semin Oncol Nurs"},{"issue":"Suppl 2","key":"11927_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6947-13-S2-S2","volume":"13","author":"A Coulter","year":"2013","unstructured":"Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):2.","journal-title":"BMC Med Inform Decis Mak"},{"key":"11927_CR12","unstructured":"IPDAS Collaboration, Collaboration Background IPDAS. Document 2005. http:\/\/ipdas.ohri.ca\/IPDAS_Background.pdf. Accessed 12 Sep 2023."},{"issue":"2","key":"11927_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"2","key":"11927_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/BLC-150029","volume":"1","author":"DL Berry","year":"2015","unstructured":"Berry DL, Nayak M, Halpenny B, Harrington S, Loughlin KR, Chang P, et al. Treatment decision making in patients with bladder Cancer. Bladder Cancer. 2015;1(2):151\u20138.","journal-title":"Bladder Cancer"},{"issue":"7","key":"11927_CR15","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.pec.2019.02.017","volume":"102","author":"A Smith","year":"2019","unstructured":"Smith A, Rincones O, Sidhom M, Mancuso P, Wong K, Berry M, et al. Robot or radiation? A qualitative study of the decision support needs of men with localised prostate cancer choosing between robotic prostatectomy and radiotherapy treatment. Patient Educ Couns. 2019;102(7):1364\u201372.","journal-title":"Patient Educ Couns"},{"key":"11927_CR16","unstructured":"EAU.: EAU guidelines - Prostate Cancer. https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/treatment (2023). Accessed 1 Nov 2023."},{"issue":"1","key":"11927_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0272989X16662841","volume":"37","author":"KA Scherr","year":"2017","unstructured":"Scherr KA, Fagerlin A, Hofer T, Scherer LD, Holmes-Rovner M, Williamson LD, et al. Physician recommendations Trump patient preferences in prostate Cancer Treatment decisions. Med Decis Making. 2017;37(1):56\u201369.","journal-title":"Med Decis Making"},{"issue":"4","key":"11927_CR18","first-page":"Cd001431","volume":"4","author":"D Stacey","year":"2017","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4(4):Cd001431.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"11927_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/0272989X10386231","volume":"30","author":"G Elwyn","year":"2010","unstructured":"Elwyn G, Frosch D, Volandes AE, Edwards A, Montori VM. Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making. 2010;30(6):701\u201311.","journal-title":"Med Decis Making"},{"key":"11927_CR20","unstructured":"van Tol-Geerdink J, van der Heijden HMA. H. Westdorp. Blaaskanker keuzehulp 2023. https:\/\/www.blaaskankerkeuzehulp.nl\/. Accesed 15 Sep 2023."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11927-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-11927-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11927-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T19:05:25Z","timestamp":1706727925000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-11927-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11927"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-11927-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethical committee of Ghent University Hospital (ONZ-2022-0037) on April 6, 2022. A signed informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Karel Decaestecker received consulting fees from Intuitive Surgical, Medtronic, Conmed, BMS, and MSD, along with support for travel\/attending meetings from Intuitive Surgical and payment for lectures\/ educational events from BMS, MSD and Intuitive Surgical. Nicolaas Lumen received grants\/contracts form Bayer and Janssen, along with support for attending meetings from Janssen and payment for lectures\/ educational events from Astellas and Sanofi. The other authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}